Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Journal of Gastrointestinal Cancer
|
March 27, 2020
Correction: Identification of Novel Pathogenic Sequence Variants of the Mismatch Repair Genes During Screening for Lynch Syndrome in a Single Centre of Eastern Hungary
Gergely Kóder, Judit Olasz, Janos L Tanyi, et al.
Journal of Gastrointestinal Cancer
|
January 16, 2020
Identification of Novel Pathogenic Sequence Variants of the Mismatch Repair Genes During Screening for Lynch Syndrome in a Single Centre of Eastern Hungary
Gergely Kóder, Judit Olasz, Janos L Tanyi, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
Controlling treatment toxicity in ovarian cancer to prime the patient for tumor extinction therapy
Kit Gallagher, Rachel S Sousa, Chandler Gatenbee, et al.
Micropublication Biology
|
April 7, 2026
Sequence Analysis of Two B1 Mycobacteriophages, ElvisPhasley and Mesmerelda
Victoria Figgins, Grace Hussey, Sarah Haimowitz, et al.
Research Square
|
February 27, 2024
Targeting <i>CCNE1</i> amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR
Haineng Xu, Erin George, David Gallo, et al.
Nature Communications
|
April 1, 2025
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR
Haineng Xu, Erin George, David Gallo, et al.
Nature Communications
|
July 26, 2020
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
Hyoung Kim, Haineng Xu, Erin George, et al.
JCO Precision Oncology
|
May 5, 2025
Training, Validating, and Testing Machine Learning Prediction Models for Endometrial Cancer Recurrence
Jesus Gonzalez Bosquet, Andrew Polio, Erin George, et al.
JCI Insight
|
January 19, 2017
A patient-derived-xenograft platform to study BRCA-deficient ovarian cancers
Erin George, Hyoung Kim, Clemens Krepler, et al.
Cell Reports. Medicine
|
October 8, 2021
<i>CCNE1</i> copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models
Haineng Xu, Erin George, Yasuto Kinose, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Journal of Gastrointestinal Cancer
|
March 27, 2020
Correction: Identification of Novel Pathogenic Sequence Variants of the Mismatch Repair Genes During Screening for Lynch Syndrome in a Single Centre of Eastern Hungary
Gergely Kóder, Judit Olasz, Janos L Tanyi, et al.
Journal of Gastrointestinal Cancer
|
January 16, 2020
Identification of Novel Pathogenic Sequence Variants of the Mismatch Repair Genes During Screening for Lynch Syndrome in a Single Centre of Eastern Hungary
Gergely Kóder, Judit Olasz, Janos L Tanyi, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
Controlling treatment toxicity in ovarian cancer to prime the patient for tumor extinction therapy
Kit Gallagher, Rachel S Sousa, Chandler Gatenbee, et al.
Micropublication Biology
|
April 7, 2026
Sequence Analysis of Two B1 Mycobacteriophages, ElvisPhasley and Mesmerelda
Victoria Figgins, Grace Hussey, Sarah Haimowitz, et al.
Research Square
|
February 27, 2024
Targeting <i>CCNE1</i> amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR
Haineng Xu, Erin George, David Gallo, et al.
Nature Communications
|
April 1, 2025
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR
Haineng Xu, Erin George, David Gallo, et al.
Nature Communications
|
July 26, 2020
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
Hyoung Kim, Haineng Xu, Erin George, et al.
JCO Precision Oncology
|
May 5, 2025
Training, Validating, and Testing Machine Learning Prediction Models for Endometrial Cancer Recurrence
Jesus Gonzalez Bosquet, Andrew Polio, Erin George, et al.
JCI Insight
|
January 19, 2017
A patient-derived-xenograft platform to study BRCA-deficient ovarian cancers
Erin George, Hyoung Kim, Clemens Krepler, et al.
Cell Reports. Medicine
|
October 8, 2021
<i>CCNE1</i> copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models
Haineng Xu, Erin George, Yasuto Kinose, et al.
Page
of 3